NCT05992597
- Conditions
- Rituximab, Lenalidomide, Zebutinib ，Mantle Cell Lymphoma
- Locations
-
- Zhejiang Cancer Hospital Hangzhou, Zhejiang, China
Clinical trial condition
Rituximab, Lenalidomide, Zebutinib ，Mantle Cell Lymphoma
Explore clinical trials studying Rituximab, Lenalidomide, Zebutinib ，Mantle Cell Lymphoma. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study